Candel Therapeutics, Inc.·4

Nov 28, 4:30 PM ET

Amello Jason 4

4 · Candel Therapeutics, Inc. · Filed Nov 28, 2023

Insider Transaction Report

Form 4
Period: 2023-11-26
Amello Jason
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-11-26+125,717222,162 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on June 30, 2024, and the remaining 50% on December 31, 2024, in each case subject to the Reporting Person's continued service on such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION